Skip to main content
Premium Trial:

Request an Annual Quote

Exosome Diagnostics ExoDx Lung (ALK)

Exosome Diagnostics has launched ExoDx Lung (ALK), a liquid biopsy test designed to isolate and analyze exosomal RNA from a blood sample. The test has been validated in Exosome's CLIA-certified laboratory. ExoDx is a plasma-based diagnostic test that enables sensitive, accurate, and real-time detection of EML4-ALK mutations in patients with non-small cell lung cancer. EML4-ALK is a gene fusion found in a subset of patients with NSCLC and predicts response to ALK inhibitor therapies. The test is the first in a series of 2016 planned diagnostics launches for the company. 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.